Grants Awarded
Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.
New awards will be posted as they are issued.
| Year |
Award Type |
Project # | RFA # | PI/Project Leader | Institution | Title | Status |
|---|---|---|---|---|---|---|---|
| 2005 | R21 | CA112220 | RFA-CA-05-004 | GASTON, SANDRA MARLENE | BETH ISRAEL DEACONESS MEDICAL CENTER | TISSUE PRINT MICROPEELS FOR MOLECULAR PROFILING CANCER | Complete |
| 2008 | R21 | CA134299 | RFA-CA-07-035 | LU, HANG | GEORGIA INSTITUTE OF TECHNOLOGY | MICROFLUIDIC SYSTEM FOR HIGH-THROUGHPUT EVALUATION OF T CELL FUNCTIONALITY WITH H | Complete |
| 2011 | R21 | CA140080 | RFA-CA-10-005 | STRAUSS, STEVEN H. | COLORADO STATE UNIVERSITY | NANOCAGED METAL TAGS IN MASSIVELY MULTIPLEXED LEUKEMIA BIOASSAY AND BEYOND | Complete |
| 2015 | R21 | CA191179 | RFA-CA-14-005 | QIN, LIDONG | METHODIST HOSPITAL RESEARCH INSTITUTE | HIGH THROUGHPUT SINGLE-CELL PHENOTYPE ISOLATION BY PROTRUSION ANALYSIS CHIP (PAC) | Complete |
| 2022 | R21 | CA269103 | CA21-003 | BLAINEY, PAUL CLARK | BROAD INSTITUTE, INC. | Stitch-seq for genome-wide pooled genomic screening with RNA-seq readout | Active |
| 2010 | R21 | CA151197 | RFA-CA-09-008 | MITRA, ROBI D | WASHINGTON UNIVERSITY | HIGHLY PARALLEL EDMAN SEQUENCING OF INDIVIDUAL PEPTIDE MOLECULES | Complete |
| 2021 | R21 | CA256084 | CA20-017 | DI CARLO, DINO | UNIVERSITY OF CALIFORNIA LOS ANGELES | Lab on a particle technology for functional screening of therapeutic cells | Complete |
| 2007 | R21 | CA125693 | RFA-CA-07-001 | LINK, DARREN R | RAINDANCE TECHNOLOGIES, INC. | EXON SPECIFIC SEQUENCING OF WHOLE GENOMIC DNA | Complete |
| 2006 | R21 | CA122890 | RFA-CA-06-003 | HAAB, BRIAN B. | VAN ANDEL RESEARCH INSTITUTE | DEFINING SECRETED GLYCAN ALTERATIONS IN PANCREATIC CANCER | Complete |
| 2009 | R21 | CA137695 | RFA-CA-08-006 | MANALIS, SCOTT R | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | DEVELOPING A SINGLE CELL GROWTH MONITOR FOR CLASSIFYING THERAPEUTIC RESPONSE | Complete |
| 2016 | R21 | CA202852 | RFA-CA-15-002 | HELD, JASON M. | WASHINGTON UNIVERSITY | DEVELOPMENT OF NOVEL CHEMICAL PROBES TO MAP S-NITROSYLATION IN CANCER | Complete |
| 2000 | R21 | CA088343 | PAR-99-100 | WANG, BINGHE | NORTH CAROLINA STATE UNIVERSITY RALEIGH | FLUORESCENT TAGS TARGETED ON CELL SURFACE CARBOHYDRATES | Complete |
| 2005 | R21 | CA112149 | RFA-CA-05-004 | MELDRUM, DEIRDRE R. | UNIVERSITY OF WASHINGTON | AUTOMATED CELL PREPARATION IN TUBES FOR 3D MICROSCOPY | Complete |
| 2008 | R21 | CA125397 | RFA-CA-07-035 | EDWARDS, JEREMY S. | UNIVERSITY OF NEW MEXICO | SEQUENCING CHR. 6 IN MELANOMA PATIENTS | Complete |
| 2011 | R21 | CA155424 | RFA-CA-10-005 | LAVIE, ARNON | UNIVERSITY OF ILLINOIS AT CHICAGO | ENZYME-DELIVERY SCAFFOLD TECHNOLOGY FOR TARGETED CANCER KILLING. | Complete |
| 2015 | R21 | CA196455 | RFA-CA-14-005 | GERTZ, JASON | UNIVERSITY OF UTAH | DEVELOPMENT OF ENHANCER RNA-BASED BIOMARKERS IN FFPE TISSUE | Complete |
| 2022 | R21 | CA272014 | CA21-003 | SALIPANTE, STEPHEN J | UNIVERSITY OF WASHINGTON | Efficient, cost-effective, and ultrasensitive sequencing of somatic mutations | Active |
| 2010 | R21 | CA143177 | RFA-CA-09-008 | LEE, CHENG S | UNIV OF MARYLAND, COLLEGE PARK | CITP-BASED SELECTIVE TISSUE PROTEOME ENRICHMENT | Complete |
| 2021 | R21 | CA258013 | CA20-019 | NAUTIYAL, SHIVANI | PRIME GENOMICS, INC. | Device for Preservation of Cell Free RNA in Saliva | Complete |
| 2007 | R21 | CA116103 | RFA-CA-07-002 | XU, XIAOWEI | UNIVERSITY OF PENNSYLVANIA | ULTRASENSITIVE FACTT ASSAYS FOR SERUM BIOMARKERS | Complete |
| 2020 | R21 | CA246457 | RFA-CA-19-019 | HATTORI, TAKAMITSU | NEW YORK UNIVERSITY SCHOOL OF MEDICINE | Rational Generation Of High-performance Recombinant Antibodies To Post-translational Modifications | Active |